Ajay Major, Founder and President of Pager Publications and Assistant Professor of Medicine at the University of Colorado School of Medicine, shared a post on X:
“RT primary cutaneous indolent B-NHL
- 535 pts with limited PC MZL/FL
- median 24 Gy
- ORR 95% (CR 91%)
- 5-yr local control 93%, OS 94%
- RT ≤4 Gy: ORR 90% (CR 84%), but much less local control (73% vs 96%)
- more Gy = more erythema
RT highly effective for cutaneous iNHL; 4 Gy attractive for future adapted trials (or avoiding time tox).”
Title: Radiotherapy for indolent primary cutaneous B-cell lymphoma: an international multicenter ILROG analysis
Authors: Michael Oertel, Bouthaina Dabaja, Dennis Görlich, Bjorn Thomas, Van Sim, Philippa Johnstone, Ayesha Hashmi, Mario Levis, Bradley Ackerson, Christina Hague, Christopher Weil, John Plastaras, Daniel Roos, Youlia Kirova, Rainer Fietkau, Penny Fang, Andrea Ng, Felix Bock, Yolanda Tseng, Philipp Linde, Jürgen Dunst, Stephanie Terezakis, Teresa Easwaran, Jan Peeken, Andrea Wittig, Hong In Yoon, Randa Tao, Timothy Illidge, Chris Kelsey, Umberto Ricardi, Michael Binkley, Belinda Campbell, Stephen Morris, Khaled Elsayad, Michael Storck, Richard Hoppe, Hans Theodor Eich
Read the Full Article.
Other articles about radiotherapy on OncoDaily.